A Prognostic Signature for Colon Adenocarcinoma Patients Based on m6A-Related lncRNAs

Figure 5

Construction and validation of prognostic signature. (a, b) Calculation of the optimal λ in Lasso regression analysis. (c) 13 prognosis lncRNAs and each of its coefficients. (d, e) The K M survival curves and ROC curves in training cohort. (g, h) The K M survival curves and ROC curves in validation cohort. (f, i) Survival time scatter plots and risk score distribution plots in training set and internal validation set.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)